Full metadata record

DC FieldValueLanguage
dc.contributor.author배애님-
dc.contributor.author임상민-
dc.contributor.author손우승-
dc.contributor.author정규성-
dc.date.accessioned2021-06-09T04:23:26Z-
dc.date.available2021-06-09T04:23:26Z-
dc.date.issued2019-05-
dc.identifier.citationVOL 29, NO 10-1172-
dc.identifier.issn0960-894X-
dc.identifier.other53868-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/70487-
dc.description.abstractHighly effective and safe drugs for the treatment of neuropathic pain are urgently required and it was shown that blocking T-type calcium channels can be a promising strategy for drug development for neuropathic pain. We have developed pyrrolidine-based T-type calcium channel inhibitors by structural hybridization and subsequent assessment of in vitro activities against Cav3.1 and Cav3.2 channels. Profiling of in vitro ADME properties of compounds was also carried out. The representative compound 17h showed comparable in vivo efficacy to gabapentin in the SNL model, which indicates T-type calcium channel inhibitors can be developed as effective therapeutics for neuropathic pain.-
dc.publisherBioorganic & medicinal chemistry letters-
dc.subjectNeuropathic pain-
dc.subjectT-type calcium channel-
dc.titleStructural hybridization of pyrrolidine-based T-type calcium channel inhibitors and exploration of their analgesic effects in a neuropathic pain model-
dc.typeArticle-
dc.relation.page11681172-
Appears in Collections:
KIST Publication > Article
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE